financetom
Business
financetom
/
Business
/
Dutch authority RDW to test Tesla's FSD in February
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dutch authority RDW to test Tesla's FSD in February
Nov 24, 2025 10:09 AM

Nov 24 (Reuters) -

The Dutch vehicle authority RDW said on Monday it expects to

decide on Tesla's Full Self-Driving software in

February after the EV maker demonstrates that the driver

assistance system meets the required standards.

The agency was responding to Tesla's post on X on Friday, in

which it said the RDW "has committed to granting the company the

Netherlands National approval" in February.

"Upon NL National approval, other EU countries can

immediately recognize the exemption and also allow rollout

within their country. Then we will bring it to a TCMV (Technical

Committee on Motor Vehicles) vote for official EU-wide

approval," Tesla had said.

Tesla had urged customers to contact RDW to "express

excitement and thank them for making this happen as soon as

possible." But RDW on Monday asked them to stop contacting the

agency.

"Road safety remains the RDW's top priority: approval is

only possible once the safety of the system has been

convincingly demonstrated," it said.

CEO Elon Musk earlier this month said he expects Tesla's FSD

to be fully approved in China early next year.

The U.S. National Highway Traffic Safety Administration in

October said it is opening an investigation into 2.88 million

FSD-equipped Tesla vehicles over more than 50 reports of

traffic-safety violations and a series of crashes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2025 - www.financetom.com All Rights Reserved